Previous close | 1.2800 |
Open | 1.9800 |
Bid | 0.0000 |
Ask | 4.0000 |
Strike | 165.00 |
Expiry date | 2025-01-17 |
Day's range | 1.2800 - 1.9800 |
Contract range | N/A |
Volume | |
Open interest | 11 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...